Scientific and Medical Equipment House (4014) Fundamentals 2026 — P/E 28.6x, Revenue Analysis | SniperIQ
Scientific and Medical Equipment House (4014) is a SA-listed Healthcare company in Medical - Equipment & Services with a market capitalization of SAR 831M, trading at SAR 27.70 on the SAU. This SniperIQ fundamentals page covers Scientific and Medical Equipment House's valuation (P/E 28.6x, P/B 1.6x), profitability (net margin 3.4%), revenue (SAR 877M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Scientific and Medical Equipment House's market cap?
Scientific and Medical Equipment House (4014) has a market capitalization of approximately SAR 831M, trading at SAR 27.70 on the SAU. Market cap moves with the live share price.
What is Scientific and Medical Equipment House's P/E ratio?
Scientific and Medical Equipment House's trailing twelve-month P/E ratio is 28.6x, with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Scientific and Medical Equipment House?
Scientific and Medical Equipment House runs a net profit margin of 3.4%, a gross margin of 13.4%, and an operating margin of 4.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Scientific and Medical Equipment House generate?
Scientific and Medical Equipment House reported revenue of SAR 877M for fiscal year 2025, with net income of SAR 28M and earnings per share (EPS) of 0.95. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Scientific and Medical Equipment House pay a dividend?
Scientific and Medical Equipment House offers a trailing dividend yield of about 7.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Scientific and Medical Equipment House financially healthy?
Scientific and Medical Equipment House carries a debt-to-equity ratio of 0.35x and a current ratio of 2.44x, with a market beta of 0.14. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Scientific and Medical Equipment House a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Scientific and Medical Equipment House (4014) the key facts are: market cap SAR 831M, P/E 28.6x, revenue SAR 877M, 52-week range 26-41. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Scientific and Medical Equipment House's full fundamentals live
Get Scientific and Medical Equipment House's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.